Amariliz Rivera

Dr. Amariliz Rivera


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
VEVanessa Espinosa
Vanessa Espinosa
ODOrchi Dutta
Orchi Dutta
CMConstance McElrath
Constance McElrath
PDPeicheng Du
Peicheng Du
YCYun-juan Chang
Yun-juan Chang
ARAmariliz Rivera
Amariliz Rivera
Type III interferons activate neutrophils to promote antifungal immune responses to Aspergillus fumigatus .

20 February 2014 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
VEVanessa Espinosa
Vanessa Espinosa
AJAnupam Jhingran
Anupam Jhingran
ODOrchi Dutta
Orchi Dutta
SKShinji Kasahara
Shinji Kasahara
RDRobert Donnelly
Robert Donnelly
ARAmariliz Rivera
Amariliz Rivera
Aspergillus fumigatus is an environmental fungus that causes invasive aspergillosis (IA) in immunocompromised patients. Although -CC-chemokine receptor-2 (CCR2) and Ly6C-expressing inflammatory monocytes (CCR2+Mo) and their derivatives initiate adaptive pulmonary immune responses, their role in coordinating innate immune responses in the lung remain poorly defined. Using conditional and antibody-mediated cell ablation strategies, we found that CCR2+Mo and monocyte-derived dendritic cells (Mo-DCs) are essential for innate defense against inhaled conidia. By harnessing fluorescent Aspergillus reporter (FLARE) conidia that report fungal cell association and viability in vivo, we identify two mechanisms by which CCR2+Mo and Mo-DCs exert innate antifungal activity. First, CCR2+Mo and Mo-DCs condition the lung inflammatory milieu to augment neutrophil conidiacidal activity. Second, conidial uptake by CCR2+Mo temporally coincided with their differentiation into Mo-DCs, a process that resulted in direct conidial killing. Our findings illustrate both indirect and direct functions for CCR2+Mo and their derivatives in innate antifungal immunity in the lung. Despite the significant impact of fungal infections to human health our understanding of immunity to these pathogens remains incomplete. Human mycoses are associated with high morbidity and mortality, even with modern antifungal therapies. Aspergillus fumigatus is the most common etiologic agent of invasive aspergillosis (IA), a serious infection that develops in immunodeficient patients. In this study we employ a combination of cell ablation strategies to examine the role of CCR2+Ly6C+ inflammatory monocytes (CCR2+Mo) in innate responses against a pulmonary infection with A.fumigatus conidia. We find that CCR2+Mo and their derivative dendritic cells (Mo-DCs) are required for defense against IA and that mice lacking these cells succumb to infection with A.fumigatus. Our studies indicate that CCR2+Mo and Mo-DCs exert crucial innate antifungal defense by two main mechanisms: 1) CCR2+Mo and Mo-DCs are a significant source of inflammatory mediators that augment the killing capacity of neutrophils and 2) conidial uptake by CCR2+Mo is coincident with their differentiation into Mo-DCs that directly kill fungal conidia via partially NADPH oxidase-dependent mechanisms. In aggregate, our studies find a novel essential function for CCR2+Mo in innate defense against a pulmonary fungal pathogen by mediating indirect and direct containment of fungal cells at the portal of infection.

11 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
CMConstance McElrath
Constance McElrath
VEVanessa Espinosa
Vanessa Espinosa
JLJian-Da Lin
Jian-Da Lin
JPJianya Peng
Jianya Peng
RSRaghavendra Sridhar
Raghavendra Sridhar
SKSergei V. Kotenko
Sergei V. Kotenko
The etiology of ulcerative colitis is poorly understood and is likely to involve perturbation of the complex interactions between the mucosal immune system and the commensal bacteria of the gut, with cytokines acting as important cross-regulators. Here we use IFN receptor-deficient mice in a dextran sulfate sodium (DSS) model of acute intestinal injury to study the contributions of type I and III interferons (IFN) to the initiation, progression and resolution of acute colitis. We find that mice lacking both types of IFN receptors exhibit enhanced barrier destruction, extensive loss of goblet cells and diminished proliferation of epithelial cells in the colon following DSS-induced damage. Impaired mucosal healing in double IFN receptor-deficient mice is driven by decreased amphiregulin expression, which IFN signaling can up-regulate in either the epithelial or hematopoietic compartment. Together, these data underscore the pleiotropic functions of IFNs and demonstrate that these critical antiviral cytokines also support epithelial regeneration following acute colonic injury.

3 March 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
VEVanessa Espinosa
Vanessa Espinosa
ARAmariliz Rivera
Amariliz Rivera
Mycotic infections and their effect on the human condition have been widely overlooked and poorly surveilled by many health organizations even though mortality rates have increased in recent years. The increased usage of immunosuppressive and myeloablative therapies for the treatment of malignant as well as non-malignant diseases has contributed significantly to the increased incidence of fungal infections. Invasive fungal infections have been found to be responsible for at least 1.5 million deaths worldwide. About 90% of these deaths can be attributed to Cryptococcus, Candida, Aspergillus, and Pneumocystis. A better understanding of how the host immune system contains fungal infection is likely to facilitate the development of much needed novel antifungal therapies. Innate cells are responsible for the rapid recognition and containment of fungal infections and have been found to play essential roles in defense against multiple fungal pathogens. In this review we summarize our current understanding of host-fungi interactions with a focus on mechanisms of innate cell-mediated recognition and control of pulmonary aspergillosis.

24 December 2019 in mBio
Verified
Journal Article
Open access
PDF file
YWYina Wang
Yina Wang
KWKeyi Wang
Keyi Wang
JMJorge A. Masso-Silva
Jorge A. Masso-Silva
ARAmariliz Rivera
Amariliz Rivera
Chaoyang XueChaoyang Xue
Chaoyang Xue
Invasive fungal infections kill more than 1.5 million people each year, with limited treatment options. There is no vaccine available in clinical use to prevent and control fungal infections. Our recent studies showed that a mutant of the F-box protein Fbp1, a subunit of the SCF(Fbp1) E3 ligase in Cryptococcus neoformans , elicited superior protective Th1 host immunity. Here, we demonstrate that the heat-killed fbp1 Δ cells (HK-fbp1) can be harnessed to confer protection against a challenge by the virulent parental strain, even in animals depleted of CD4 + T cells. This finding is particularly important in the context of HIV/AIDS-induced immune deficiency. Moreover, we observed that HK-fbp1 vaccination induces significant cross-protection against challenge with diverse invasive fungal pathogens. Thus, our data suggest that HK-fbp1 has the potential to be a broad-spectrum vaccine candidate against invasive fungal infections in both immunocompetent and immunocompromised populations.

7 March 2018 in mBio
Verified
Journal Article
Open access
PDF file
JMJorge Masso-Silva
Jorge Masso-Silva
VEVanessa Espinosa
Vanessa Espinosa
Tong-Bao LIUTong-Bao LIU
Tong-Bao LIU
YWYina Wang
Yina Wang
Chaoyang XueChaoyang Xue
Chaoyang Xue
ARAmariliz Rivera
Amariliz Rivera
Cryptococcus neoformans is the main etiologic agent of cryptococcal meningitis and causes a significant number of deadly infections per year. Although it is well appreciated that host immune responses are crucial for defense against cryptococcosis, our understanding of factors that control the development of effective immunity to this fungus remains incomplete. In previous studies, we identified the F-box protein Fbp1 as a novel determinant of C. neoformans virulence. In this study, we found that the hypovirulence of the fbp1 Δ mutant is linked to the development of a robust host immune response. Infection with the fbp1 Δ mutant induces a rapid influx of CCR2 + monocytes and their differentiation into monocyte-derived dendritic cells (mo-DCs). Depletion of CCR2 + monocytes and their derivative mo-DCs resulted in impaired activation of a protective inflammatory response and the rapid death of mice infected with the fbp1 Δ mutant. Mice lacking B and T cells also developed fungal meningitis and succumbed to infection with the fbp1 Δ mutant, demonstrating that adaptive immune responses to the fbp1 Δ mutant help to maintain the long-term survival of the host. Adaptive immune responses to the fbp1 Δ mutant were characterized by enhanced differentiation of Th1 and Th17 CD4 + T cells together with diminished Th2 responses compared to the H99 parental strain. Importantly, we found that the enhanced immunogenicity of fbp1 Δ mutant yeast cells can be harnessed to confer protection against a subsequent infection with the virulent H99 parental strain. Altogether, our findings suggest that Fbp1 functions as a novel virulence factor that shapes the immunogenicity of C. neoformans . IMPORTANCE Cryptococcus neoformans is the most common cause of deadly fungal meningitis, with over 270,000 infections per year. Immune responses are critically required for the prevention of cryptococcosis, and patients with impaired immunity and low CD4 + T cell numbers are at high risk of developing these deadly infections. Although it is well appreciated that the development of protective immunity is shaped by the interactions of the host immune system with fungal cells, our understanding of fungal products that influence this process remains poor. In this study, we found that the activity of F-box protein 1 (Fbp1) in highly virulent C. neoformans clinical strain H99 shapes its immunogenicity and thus affects the development of protective immune responses in the host. The identification of this new mechanism of virulence may facilitate the future development of therapeutic interventions aimed at boosting antifungal host immunity.